FDA Inspection 1063022 — Oklahoma Blood Institute East Central
The FDA completed an inspection of Oklahoma Blood Institute East Central on Aug 3, 2018 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 3, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ada, OK (United States)